In this study, we demonstrated that MeCP2 was markedly different in pancreatic cancer tissues, enhanced the proliferation, migration, and invasion abilities of pancreatic cancer cells, and promoted tumorigenesis. This evidence concerns the gene MECP2 and familial pancreatic carcinoma.